Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a leading provider of laboratory instruments, reagents and consumables, diagnostics, software and related services that support scientific research, clinical diagnostics and pharmaceutical development. The company serves a broad set of customers including academic and government research institutions, pharmaceutical and biotechnology companies, clinical and hospital laboratories, and industrial and environmental testing organizations. Its offerings span laboratory equipment and instruments, analytical and life‑science reagents, contract development and manufacturing services (CDMO), and enterprise software and services that enable discovery, development and production workflows. Formed by the merger of Thermo Electron and Fisher Scientific and operating under the Thermo Fisher Scientific name since 2006, the company is headquartered in Waltham, Massachusetts and maintains a global footprint across more than 50 countries. Thermo Fisher is a major global player in the life sciences and laboratory equipment sector, employing well over 100,000 people worldwide and listed on the NYSE under ticker TMO. The company distinguishes itself through a history of strategic acquisitions (notably Life Technologies in 2014 and PPD in 2021), extensive manufacturing and service capacity, and collaborations with governments and major pharmaceutical firms—for example supporting diagnostics and manufacturing scale‑up during the COVID‑19 pandemic. As a publicly traded company, it uses capital markets and acquisition activity to finance growth, expand its CDMO capabilities and invest in R&D and global manufacturing capacity.